摘要
4分期与评分
甲状腺结节(TN)的分期常在手术后获得病理学资料时才能判定,故又称术后分期。据监视、流行病学、最终结果(surveillance epidemiology and end result,SEER)总结资料,TN组织学分期与5年生存率有密切关系。如肿瘤局限在甲状腺内,其5年生存率为99.7%;肿瘤扩散到局部区域淋巴结时降至96.9%;有远处转移时仅57.8%。
出处
《中华内分泌外科杂志》
CAS
2011年第4期217-218,234,共3页
Chinese Journal of Endocrine Surgery
参考文献13
-
1Lang BH, Lo CY,Chan WF, et al. Staging systems for papillary thyroid carcinoma : a review and comparison [ J ]. Ann Surg,2007, 245 ( 3 ) :366-378.
-
2White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer [ J ]. WoAd J Surg, 2007,31 ( 5 ) : 895 -904.
-
3Mazzaferri EL, Kloos RT. Clinical review 128:Current approaches to primary therapy for papillary and follicular thyroid cancer [ J ]. J Clin Endocrinol Metab ,2001,86 (4) : 1447-1463.
-
4Sywak M, Comford L, Roach P, et al. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer [ J ]. Surgery,2006,140 (6) : 1000-1005.
-
5Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection [ J ]. Arch Otolaryngol Head Neck Surg,2008,134( 5 ) :536-538.
-
6Low TH, Delbridge L, Sidhu S, et al. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer [J]. Ann Surg Oncol,2008,15(10):2827-2832.
-
7Lopez-Penabad L, Chiu AC, Hoff AO, et al. Prognostic factors in patients with Htirthle cell neoplasms of the thyroid [ J ]. Cancer, 2003,97 (5) : 1186-1194.
-
8Brierley JD, Tsang RW. External beam radiation therapy for thyroid cancer[J]. Endocrinol Metab Clin North Am,2008,37 (2): 497-509.
-
9Grodski S, Delbridge L. An update on papillary microcarcinoma [ J]. Curr Opin Onco1,2009,21 ( 1 ) : 1-4.
-
10Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thy- roid microcarcinoma : a study of 900 cases observed in a 60-year period[ J]. Surgery,2008,144 (6) :980-987.
同被引文献33
-
1朱永学,王弘士,吴毅,嵇庆海,黄彩萍.甲状腺乳头状癌Ⅵ区淋巴结的归属[J].中华外科杂志,2004,42(14):867-869. 被引量:112
-
2陈福进,李秋梨,曾宗渊,宋明,杨安奎,张诠.分化型甲状腺癌的治疗及影响复发的因素分析[J].癌症,2004,23(11):1311-1316. 被引量:50
-
3宋明,陈文宽,陈福进,杨安奎,魏茂文.Ⅵ区淋巴清扫在甲状腺癌外科手术中的意义[J].癌症,2006,25(11):1411-1413. 被引量:15
-
4王家东,邓星程,金晓杰,张淳,周佳青,周秦毅,刘君,钱敏飞.前哨淋巴结探查在甲状腺乳头状癌外科手术中的应用[J].临床耳鼻咽喉头颈外科杂志,2007,21(12):543-544. 被引量:9
-
5Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preopera- tive uhrasonography in the surgical management of patients with thyroid cancer[ J ]. Surgery,2003,134 (6) :946-955.
-
6Kinder BK. Well differentiated thyroid cancer [ J]. Curr Opin On- col,2003,15 ( 1 ) : 71-77.
-
7Shindo M, Wu JC, Park EE, et al. The importance of central com- partment elective lymph node excision in the staging and treatment of papillary thyroid cancer[ J ]. Arch Otolaryngol Head Neck Surg, 2006,132 (6) :650-654.
-
8Watkinson JC, Franklyn JA, Olliff JF. Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer [ J ]. Thyroid,2006,16 ( 2 ) : 187-194.
-
9Roy B, Terry T, Carrie A. Cancer of the thyroid gland[ A]. Louis B,Roy B, Waun KH. Head and neck cancer:A multidisciplinary approach [ M ]. Philadelphia: Lippincot t-raven, 1998 : 807-808.
-
10Sugitani I, Kasai N, Fujimoto Y, et al. A novel classification sys- tem for patients with PTC: addition of the new of large(3cm or greater) nodal metastases and reclassification during the follow-up period [ J ]. Surgery ,2004,135 ( 2 ) : 139-148.
引证文献2
-
1朱正志,王圣应,张晖,彭德峰,朱金海,张荣新,姚廷敬,王子岩.中央区淋巴结清扫在分化型甲状腺癌外科手术中的意义[J].中华内分泌外科杂志,2012,6(4):234-236. 被引量:11
-
2杨春明.甲状腺癌的分期系统和治疗选择[J].中华内分泌外科杂志,2012,6(4):247-249. 被引量:2
二级引证文献13
-
1曾宪明,陈继红,甘小海,姚慧梅,王银枚,刘社芽,周耀明.四维彩超+TSH在甲状腺癌诊断中的临床价值[J].中外医学研究,2013,11(11):43-44.
-
2王磊,王岭,凌瑞,张聚良,王廷.预防性中央区淋巴结清扫在颈淋巴结阴性分化型甲状腺癌手术中的应用效果评价[J].实用临床医药杂志,2013,17(11):41-43. 被引量:12
-
3王海岭,韩景致,王云峰,金照凯,叶财盛.SND在颈部高危cN0甲状腺癌患者中的应用价值[J].西南国防医药,2015,25(1):4-7. 被引量:1
-
4王海岭,王云峰,金照凯.颈部淋巴结选择性清扫对甲状腺癌患者的临床应用观察[J].安徽医药,2015,19(1):140-141. 被引量:6
-
5徐淑芠,邢朝晖,赵臣,徐志,褚波,李培华.选择性颈部淋巴结清扫在甲状腺癌根治术中的应用价值分析[J].中国医刊,2015,50(11):82-84. 被引量:3
-
6郭登方,张扬平,陈春,余振兴,王瑞华.颈淋巴结清扫在分化型甲状腺癌手术中的应用[J].中国医药指南,2016,14(25):177-178. 被引量:1
-
7陈华,雷小添.Cyfra 21-1表达与分化型甲状腺癌临床病理特征及其预后的相关性[J].临床与病理杂志,2017,37(5):937-942. 被引量:4
-
8侯伟,李佳,谢守凤,张业强.甲状腺乳头状癌颈淋巴结转移规律与手术方式的选择[J].现代肿瘤医学,2017,25(16):2576-2580. 被引量:5
-
9高文祥,王中阳.术前高频彩超指导分化型甲状腺癌淋巴结清扫的应用[J].中国医疗设备,2017,32(3):62-65. 被引量:6
-
10周科,潘俊峰,龙斌斌,李文仿,王耕.中央淋巴结清扫术治疗分化型甲状腺癌的临床疗效及预后分析[J].实用临床医药杂志,2018,22(3):63-65. 被引量:15
-
1江小梅,彭杰文,杨志锋.血管内皮生长因子-C蛋白及mRNA的表达与胃癌预后的关系[J].广东医学,2014,35(10):1549-1551. 被引量:3
-
2原晓燕,王全胜,李捷,刘梅,张艳君,王建东,李席如.乳腺浸润性微乳头状癌97例临床分析[J].中华乳腺病杂志(电子版),2015,9(6):367-371. 被引量:5
-
3邹伟,朱淑玲,张欢.雄激素受体与蛋白激酶B在三阴性乳腺癌的表达及其预后意义[J].包头医学院学报,2015,31(12):4-5. 被引量:2
-
4陈秀娇,蔡庆发.Survivin、PCNA在乳腺癌中的表达及其意义[J].海南医学院学报,2005,11(4):259-262.
-
5马可,王慧,王清华,雒舒雅,魏敏杰,肖庆桓.老年女性乳腺浸润性导管癌患者ER等生物标志物对预后的影响[J].中国卫生统计,2016,33(3):448-449. 被引量:1
-
6李兰玉,张蔚,郭婉茹,张文婷,钟亚娟.EZH2基因在子宫颈鳞状细胞癌中的表达及其意义[J].肿瘤研究与临床,2012,24(2):88-90.
-
7王坤,周清,郑登云,廖宁,李学瑞.p53、bcl-2和CD44v6蛋白表达与乳腺癌转移的相关性研究[J].肿瘤防治研究,2005,32(12):748-751. 被引量:5
-
8李兰玉,张蔚,郭婉茹,张文婷,钟亚娟.宫颈鳞癌组织中EZH2和PTEN蛋白的表达[J].中华实用诊断与治疗杂志,2012,26(6):557-559. 被引量:4
-
9张梅娟,张丽华,陈洁宇,周强,周祀侨.胃癌组织中COX-2表达及其与微血管和微淋巴管密度的关系[J].临床与实验病理学杂志,2008,24(3):309-312. 被引量:5
-
10金梅,杨成义,盛志勇,王琳,李里香,雷英.浸润性乳腺癌抑癌基因的表达意义及与ER的相关性[J].江西医学院学报,2005,45(4):137-139.